You are here
Drug Preventing Preterm Births Gets FDA Approval and Price increases
The cost of a drug that has helped some women prevent preterm labor is skyrocketing now that it's been approved by the Food and Drug Administration. The drug, formerly called 17p and now called Makena since its FDA approval, is a form of progesterone shot that has been compounded (mixed together) in some pharmacies and used since 2004. After FDA approval, the drug went from around $20 an injection to $1,500 under Makena's name.